Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2024-01-19 00:00:00 ET · period of report 2024-01-17 · accession 0000950170-24-005798 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-01-19 | 2024-01-17 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | S - Sale+OE | $83.51 | -9,030 | 83.7K | -10% | -$754.1K |
| DMI | 2024-01-19 | 2024-01-17 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $45.43 | +9,030 | 92.8K | +11% | +$410.2K |
| DMI | 2024-01-19 | 2024-01-17 | DLB | YEAMAN KEVIN J | Pres, CEO, Dir | M - OptEx | $0.00 | -9,030 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-01-17 | S | D | 9,030 | $83.51 | 83,721 | I By a trust | — | — | (F2) The shares were sold in multiple transactions at prices ranging from $83.34 to $83.92, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 2 | Common | Class A Common Stock | 2024-01-17 | M | A | 246 | $42.98 | 83,967 | I By a trust | — | — | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 3 | Common | Class A Common Stock | 2024-01-17 | M | A | 8,784 | $45.50 | 92,751 | I By a trust | — | — | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2024-01-17 | M | D | 8,784 | $0.00 | 185,615 | I By a trust | $45.50 · — to 2026-12-15 | 8,784 Class A Common Stock | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 (F5) This option was granted for a total of 194,399 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |
| 5 | Derivative | Employee Stock Option (Right to Buy) | 2024-01-17 | M | D | 246 | $0.00 | 0 | I By a trust | $42.98 · — to 2024-12-15 | 246 Class A Common Stock | (F1) By the Kevin and Rachel Yeaman Family Trust dated May 14, 2009 (F4) This option was granted for a total of 291,598 shares of Class A Common Stock. The option exercised in this transaction was fully vested and exercisable as of the transaction date. |